PRADAXA 150MG is an oral anticoagulant medication commonly used to help reduce the risk of blood clots. It works by inhibiting certain clotting factors in the blood, which can help prevent conditions such as stroke, systemic embolism, or deep vein thrombosis in patients who are at risk. It is typically prescribed for adults with specific cardiovascular conditions that require anticoagulation therapy.

Active Ingredient(s) / Generic Name

• Dabigatran etexilate mesylate 150 mg (generic: Dabigatran)

Brand Name / Manufacturer / Marketer

• Brand: PRADAXA

• Manufacturer: Boehringer Ingelheim

Indications / Uses

• Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation

• Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Reducing the risk of recurrent DVT or PE

Storage Instructions

• Store at room temperature, between 20°C and 25°C (68°F – 77°F)

• Keep the medication in its original container to protect from moisture

• Keep out of reach of children and pets

• Do not use after the expiration date printed on the packaging

Disclaimer
This description is for informational purposes only. Always follow the advice of a healthcare professional before starting, stopping, or changing the dosage of any medication. Consult your doctor or pharmacist for questions regarding the use of PRADAXA 150MG, its potential interactions, and suitability for your health condition.